FRI0457 Recommendations for The Management of Comorbidities in Psoriatic Disease. (15th July 2016)

• Record Type: Journal Article
• Authors: Torre-Alonso, J.C.; Carmona, L.; Moreno, M.; Galíndez, E.; Babío, J.; Zarco, P.; Linares, L.F.; Collantes, E.; Fernández-Barrial, M.; Hermosa, J.C.; Coto, P.; Suárez, C.; Almodόvar, R.; Luelmo, J.; Cárcaba, V.; Castañeda, S.; Gratacόs, J.
• Is Part Of: Annals of the rheumatic diseases. Volume 75(2016)Supplement 2
• Page Start: 602
• Page End: 602
• Publication Date: 2016-07-15
• Subjects: Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/annrheumdis-2016-eular.3440
• Languages: English
• ISSNs: 0003-4967

Abstract

Abstract : Objectives: To establish recommendations for the management of comorbidities in patients with psoriatic disease (PsD). Methods: A multidisciplinary panel drafted the recommendationsin a nominal group session. Evidence from four systematic reviews was added. Agreement was assessed by two-rounds Delphi technique. Recommendations with an agreement ≥7/10 by at least 70% of participants were kept in. Results: A total of 19 recommendations on three key topics were issued: 1) screening of specific comorbidities, 2) specific preventive or therapeutic actions, and 3) general management. Conclusions: Disease control coupled with the management of comorbidities is critical to ensure optimal patient care. These recommendations suggest actions on detection, management and integration of care in PsD. Acknowledgement: GECOAP project was funded by Merck Sharp & Dohme of Spain Disclosure of Interest: None declared